INDUSTRY MEMBER: AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
AstraZeneca has a deep-rooted heritage in oncology and offers a quickly growing portfolio of new medicines that has the potential to transform patients’ lives and the Company’s future. With seven new medicines launched between 2014 and 2020, and a broad pipeline of small molecules and biologics in development, the Company is committed to advance oncology as a key growth driver for AstraZeneca focused on lung, ovarian, breast and blood cancers.
By harnessing the power of six scientific platforms – Immuno-Oncology, Tumor Drivers and Resistance, DNA Damage Response, Antibody Drug Conjugates, Epigenetics, and Cell Therapies – and by championing the development of personalized combinations, AstraZeneca has the vision to redefine cancer treatment and one day eliminate cancer as a cause of death.
AstraZeneca PROGRAMS & RESOURCES
Beyond Pink: Sharing Our Metastatic Breast Cancer Story
We know that navigating a metastatic breast cancer (MBC), diagnosis isn't easy, but with proper knowledge, tips, and support, you can be well equipped to face the challenges of MBC. That’s why Beyond Pink was created—to provide useful tools and information specifically for women with MBC and their loved ones as they face this unique journey together.Link to program
YOUR Cancer spotlights the many individuals and organizations at the forefront of cancer care. It brings together patients, caregivers, advocacy groups, researchers, healthcare providers, policymakers, and everyone working to transform cancer care from one person's disease into a true community effort.Link to program